Tetramethylpyrazine reduces prostate cancer malignancy through inactivation of the DPP10‑AS1/CBP/FOXM1 signaling pathway-Reference-Cited by-同舟云学术

Tetramethylpyrazine reduces prostate cancer malignancy through inactivation of the DPP10‑AS1/CBP/FOXM1 signaling pathway

Published:2020-04-01 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Zhou Yi¹,Zhou Zhien¹,Ji Zhigang¹,Yan Weigang¹,Li Hanzhong¹,Yu Xiao²

Affiliation:

1. Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100000, P.R. China

2. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CircACTR2 attenuated the effects of tetramethylpyrazine on human kidney cell injury;Journal of Bioenergetics and Biomembranes;2024-03-01

2. Oncogenic role of FOXM1 in human prostate cancer (Review);Oncology Reports;2023-11-30

3. Inhibiting autophagy to boost antitumor immunity with tetramethylpyrazine-loaded and PD-L1-targeting liposomal nanoparticles;European Journal of Pharmaceutical Sciences;2023-11

4. Long non-coding RNA DPP10-AS1 represses the proliferation and invasiveness of glioblastoma by regulating miR-24-3p/CHD5 signaling pathway;BIOCELL;2023

5. DPP10-AS1–Mediated Downregulation of MicroRNA-324-3p Is Conducive to the Malignancy of Pancreatic Cancer by Enhancing CLDN3 Expression;Pancreas;2022-10